Gelita AG conducted a randomized controlled trial rigorously which has displayed the benefits of Gelita’s fortigel in decreasing the intensity of pain in knee joints during activity, in healthy men and women. Fortigel has been a widely studied bioactive collagen peptide for over 30 years. Over 20 studies have been conducted which involved more than 2,500 people who contributed to developing Fortigel and proving the product’s positive effects on joint health.
Darling Ingredients company that turns food waste into sustainable products and produces renewable energy from the waste has announced that it has received a U.S. patent for gelatin technology that improves soft gel capsule stability and efficacy. It is a special kind of gelatin that improves the formulation and stability of soft gel capsules to enhance the release of active ingredients, including medications.
Author Credits: Parul Atri
Report ID: 6013
Published Date: Apr 29, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The market size of collagen is USD 6.5 Billion in 2024 and is poised to reach USD 20 Billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036.
The major players in the market are Ewald Gelatine, Darling Ingredients, Ashland, Tessenderlo Group, DSM, Titan Biotech, Collagen Solutions (US) LLC, Amicogen, Inc., Regenity, Gelita AG, and others.
The marine source segment is anticipated to garner the largest market size of 45 % by 2036 and display significant growth opportunities.
The market in the Asia Pacific region is anticipated to account for 34% revenue share by the end of 2036, on account of growing awareness and demand for health and wellness products among people.